舒血宁与疏血通治疗急性脑梗死的疗效比较

Comparison of the efficacy of Shuxuening combined with Shuxuetong injection intreatment of acute cerebral infarction

目的观察率舒血宁与疏血通治疗急性脑梗死的临床疗效。方法对收治的68例急性脑梗死的患者随机分为舒血宁组(A组)和疏血通组(B组)各34例,两组均采取常规治疗,A组在常规治疗的基础上加用舒血宁注射液20 mL/d,静滴;B组则常规治疗的基础上加用疏血通6 mL/d,静滴,两组均连续用药两周,比较两组患者治疗后的临床疗效,日常生活能力(ADL)及神经功能缺损评分。结果 A组和B组总有效率分别为91.2%和88.2%。两组疗效比较差异无显著性(P>0.05)。两组治疗后ADL较治疗前明显升高,神经功能缺损评分则明显降低,差异有统计学意义(P<0.05),但两组比较差异无显著性(P>0.05)。结论舒血宁与疏血通是治疗急性脑梗死安全、有效的药物,值得临床推广应用。

Objective To observe the clinical efficacy of Shuxuening injection and the rate of Shuxuetong injection in treatment of acute cerebral infarction. Methods 68 cases of acute cerebral infarction were randomly divided into group A and B group, A group on the basis of conventional therapy plus Shuxuening,group B is based on routine treatment combined with sparse blood 6ml/d, intravenous drip, two groups were treated for two weeks, the clinical efficacy were compared. Results The two groups after treatment than before treatment significantly increased ADL, neural function defect score decreased, the difference was statistically significant （P〈0.05）, but the two groups had no signiftcant difference （P〉0.05）. Conclusion Shuxuening combined with Shuxuetong is effective for the treatment of acute cerebral infarction, safe, worthy of clinical application.